Hilde Havnen
Papers
1
Total Citations
4
H-Index
1
About
Hilde Havnen is a researcher specializing in clinical pharmacology and analytical toxicology, with a focus on chiral separation techniques for therapeutic drug monitoring. Her major contributions lie in developing robust, high-throughput methods to quantify drug enantiomers—particularly methadone—in biological matrices, addressing the critical need to distinguish pharmacologically active and inactive forms for personalized medicine. Her most-cited work, "Quantitative determination of R/S‐methadone in human serum using ultra‐high performance supercritical fluid chromatography‐tandem mass spectrometry" (2024, 4 citations), introduces a rapid, routine-compatible method that enhances precision in monitoring methadone therapy, directly impacting opioid addiction treatment and pain management. This achievement underscores her skill in merging advanced chromatography with mass spectrometry to solve real-world clinical challenges. Havnen’s research has been recognized for its potential to improve patient safety and dosing accuracy, making her a notable figure in the field of bioanalysis. Her work continues to influence the development of enantioselective assays, offering students and researchers a model for translating analytical chemistry into practical healthcare solutions.
Research Focus
Key Achievements
Top Papers
- 1